The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 20,004,194 | 2,037,087 | SH | SOLE | 2,037,087 | 0 | 0 | ||
AARDVARK THERAPEUTICS INC | COM | 002942100 | 3,877,631 | 286,807 | SH | SOLE | 286,807 | 0 | 0 | ||
ABEONA THERAPEUTICS INC | COM NEW | 00289Y206 | 5,213,661 | 917,898 | SH | SOLE | 917,898 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 38,088,955 | 713,811 | SH | SOLE | 713,811 | 0 | 0 | ||
AKERO THERAPEUTICS INC | CALL | 00973Y908 | 1,334,000 | 25,000 | SH | Call | SOLE | 25,000 | 0 | 0 | |
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 14,938,875 | 86,552 | SH | SOLE | 86,552 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 11,644,000 | 410,000 | SH | SOLE | 410,000 | 0 | 0 | ||
BENITEC BIOPHARMA INC | COM NEW | 08205P209 | 2,962,838 | 253,234 | SH | SOLE | 253,234 | 0 | 0 | ||
BIODESIX INC | COM | 09075X108 | 302,058 | 1,070,367 | SH | SOLE | 1,070,367 | 0 | 0 | ||
CAPRICOR THERAPEUTICS INC | PUT | 14070B959 | 1,436,871 | 144,700 | SH | Put | SOLE | 144,700 | 0 | 0 | |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 4,038,274 | 198,441 | SH | SOLE | 198,441 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 65,700 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
CERUS CORP | COM | 157085101 | 3,508,490 | 2,488,291 | SH | SOLE | 2,488,291 | 0 | 0 | ||
CG ONCOLOGY INC | COM | 156944100 | 14,066,884 | 541,034 | SH | SOLE | 541,034 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM NEW | 171757206 | 5,063,064 | 103,943 | SH | SOLE | 103,943 | 0 | 0 | ||
COGENT COMMUNICATIONS HLDGS | CALL | 19239V902 | 3,590,000 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
COMPASS THERAPEUTICS INC | COM | 20454B104 | 3,249,431 | 1,249,781 | SH | SOLE | 1,249,781 | 0 | 0 | ||
COMPUGEN LTD | ORD | M25722105 | 5,400,305 | 3,033,879 | SH | SOLE | 3,033,879 | 0 | 0 | ||
DELCATH SYS INC | COM NEW | 24661P807 | 1,401,154 | 103,026 | SH | SOLE | 103,026 | 0 | 0 | ||
DIANTHUS THERAPEUTICS INC | COM | 252828108 | 1,784,866 | 95,806 | SH | SOLE | 95,806 | 0 | 0 | ||
ELUTIA INC | CL A COM | 05479K106 | 5,468,134 | 2,761,684 | SH | SOLE | 2,761,684 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 200,600 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 3,263,381 | 2,569,591 | SH | SOLE | 2,569,591 | 0 | 0 | ||
FRACTYL HEALTH INC | COM | 35168W103 | 328,196 | 202,590 | SH | SOLE | 202,590 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 6,330,542 | 5,146,782 | SH | SOLE | 5,146,782 | 0 | 0 | ||
HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | 6,514,234 | 613,393 | SH | SOLE | 613,393 | 0 | 0 | ||
HIMS & HERS HEALTH INC | PUT | 433000956 | 2,492,500 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
INSMED INC | COM PAR $.01 | 457669307 | 25,065,398 | 249,060 | SH | SOLE | 249,060 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 20,712,693 | 1,832,171 | SH | SOLE | 1,832,171 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | 2,101,786 | 75,959 | SH | SOLE | 75,959 | 0 | 0 | ||
KODIAK SCIENCES INC | COM | 50015M109 | 1,497,744 | 401,540 | SH | SOLE | 401,540 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 926,013 | 3,128,421 | SH | SOLE | 3,128,421 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 39,027,727 | 741,972 | SH | SOLE | 741,972 | 0 | 0 | ||
MERUS N V | CALL | N5749R900 | 20,119,500 | 382,500 | SH | Call | SOLE | 382,500 | 0 | 0 | |
METSERA INC | COM | 59267L107 | 5,905,679 | 207,581 | SH | SOLE | 207,581 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 1,559,765 | 115,282 | SH | SOLE | 115,282 | 0 | 0 | ||
MODULAR MED INC | COM NEW | 60785L207 | 529,220 | 710,363 | SH | SOLE | 710,363 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 3,871,486 | 82,023 | SH | SOLE | 82,023 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM NEW | 640268306 | 8,941 | 346 | SH | SOLE | 346 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 20,483,574 | 162,969 | SH | SOLE | 162,969 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 17,974,983 | 235,583 | SH | SOLE | 235,583 | 0 | 0 | ||
NUVALENT INC | CALL | 670703907 | 7,645,260 | 100,200 | SH | Call | SOLE | 100,200 | 0 | 0 | |
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 18,278,414 | 1,800,829 | SH | SOLE | 1,800,829 | 0 | 0 | ||
ORUKA THERAPEUTICS INC | COM | 687604108 | 1,854,011 | 165,389 | SH | SOLE | 165,389 | 0 | 0 | ||
PFIZER INC | COM | 717081103 | 8,346,753 | 344,338 | SH | SOLE | 344,338 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 420,500 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
RADIOPHARM THERANOSTICS LTD | SPONSORED ADS | 75041J101 | 869,564 | 187,406 | SH | SOLE | 187,406 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 25,324,783 | 400,772 | SH | SOLE | 400,772 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 77313F114 | 3,019 | 104,828 | SH | SOLE | 104,828 | 0 | 0 | ||
SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | 286,047 | 37,539 | SH | SOLE | 37,539 | 0 | 0 | ||
SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 12,078,574 | 341,010 | SH | SOLE | 341,010 | 0 | 0 | ||
SIONNA THERAPEUTICS INC | COM | 829401108 | 3,227,360 | 186,015 | SH | SOLE | 186,015 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | COM | 834203309 | 17,140,634 | 204,591 | SH | SOLE | 204,591 | 0 | 0 | ||
SPDR SERIES TRUST | CALL | 78464A900 | 16,586,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 3,642,691 | 175,636 | SH | SOLE | 175,636 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,773,758 | 402,964 | SH | SOLE | 402,964 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | CALL | 87164F905 | 468,000 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
TELA BIO INC | COM | 872381108 | 5,392,802 | 2,779,795 | SH | SOLE | 2,779,795 | 0 | 0 | ||
TOURMALINE BIO INC | COM | 89157D105 | 1,747,019 | 109,257 | SH | SOLE | 109,257 | 0 | 0 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | 2,951,541 | 539,587 | SH | SOLE | 539,587 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 2,823,756 | 202,565 | SH | SOLE | 202,565 | 0 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 27,708,003 | 2,022,482 | SH | SOLE | 2,022,482 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 9,356,248 | 287,796 | SH | SOLE | 287,796 | 0 | 0 | ||
VERACYTE INC | COM | 92337F107 | 12,122,820 | 448,495 | SH | SOLE | 448,495 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 33,887,730 | 358,297 | SH | SOLE | 358,297 | 0 | 0 |